Somaxon Pharmaceuticals, Inc.
3721 Valley Centre Drive
Suite 500
San Diego,
CA 92130
United States - Map
Phone: 858-480-0400
Fax: 858-509-1761
Web Site: http://www.somaxon.com
| Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology. The company has completed four Phase III clinical trials for its lead product candidate, Silenor (doxepin hydrochloride) for the treatment of insomnia. Somaxon Pharmaceuticals, Inc. was founded in 2003 and is headquartered in San Diego, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. David F. Hale , 59
Co-Founder and Exec. Chairman |
$
325.00K |
$
0 | Mr. Richard W. Pascoe , 45
Chief Exec. Officer, Pres, Principal Financial Officer |
$
163.00K |
$
0 | Mr. Jeffrey W. Raser , 48
Co-founder and Sr. VP of Sales & Marketing |
$
307.00K |
$
0 | Mr. Matthew W. Onaitis , 38
VP, Sec. and Gen. Counsel |
N/A
| N/A | Dr. Neil Kavey M.D,
Consultant and Member of the Scientific Advisory Board |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.48% Nasdaq 
0.16 (5.63%) 
Profile
